طرق متوسط وقت البقاء المقيد مع تطبيق على بيانات سرطان الثدي

[1] Abulizi, Xianmixikemaier, Heather J. Ribaudo, and Philippe Flandre. 2019. The Use of the Restricted Mean Survival Time as a Treatment Measure in HIV/AIDS Clinical Trial: Reanalysis of the ACTG A5257 Trial. DOI: https://doi.org/10.1097/QAI.0000000000001978

[2] A’Hern, Roger P. 2016. ‘Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?’ Journal of Clinical Oncology 34(28):3474–76. https://doi: 10.1200/JCO.2016.67.8045. DOI: https://doi.org/10.1200/JCO.2016.67.8045

[3] Calkins, Keri L., Chelsea E. Canan, Richard D. Moore, Catherine R. Lesko, and Bryan Lau. 2018. ‘An Application of Restricted Mean Survival Time in a Competing Risks Setting: Comparing Time to ART Initiation by Injection Drug Use’. BMC Medical Research Methodology 18(1). https://doi: 10.1186/s12874-018-0484-z. DOI: https://doi.org/10.1186/s12874-018-0484-z

[4] Chiumente, Marco, Daniele Mengato, and Andrea Messori. 2020. ‘Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median’. Acta Haematologica 143(6):598–99. DOI: https://doi.org/10.1159/000505891

[5] He, Yifan, and Yong Zhou. 2020. ‘Nonparametric and Semiparametric Estimators of Restricted Mean Survival Time under Length-Biased Sampling’. Lifetime Data Analysis 26(4):761–88. https://doi: 10.1007/s10985-020-09498-x. DOI: https://doi.org/10.1007/s10985-020-09498-x

[6] Hajer, F. T., & Ibrahim, W. S. (2029). Use the logistic regression model to find the most critical factors affecting lung cancer in Iraq in 2017, Journal of Administration and Economics, 44(121).

[7] Ibrahim, W. S., & Jaber. A. K. A. (2023). A study of patient with bladder cancer using the survival function of the new expanded adapter Whipple distribution. Journal of Administration and Economics, 48(139). https://doi.org/10.31272/jae.i139.1090 DOI: https://doi.org/10.31272/jae.i139.1090

[8] Inam, D. R., Noaman, A., Huda,  A L, Abd, A., &  A.-A. (2019). Comparison of Classical and Bayesian methods to Estimate the shape parameter and Reliability function in Burr type X or two param4eter of exponential Rayleigh distribution under different Loss function. https://doi.org/10.31272/JAE.42.2019.11

[9] Jackson, Richard J. 2015. Some Statistical Methods for the Analysis of Survival Data in Cancer Clinical Trials.

[10] Mawlood, Kurdistan I., & Obed, Sami A. (2019). QALAAI ZANIST SCIENTIFIC JOURNAL Study and Analysis of the Chest Cancer Data Using Survival Models ARTICLE INFO ABSTRACT. A Scientific Quarterly Refereed Journal Issued by Lebanese French University-Erbil, 4. https://doi.org/10.25212/lfu.qzj.4.2.24

[11] Lyu, Jingjing, Yawen Hou, and Zheng Chen. 2020a. ‘The Use of Restricted Mean Time Lost under Competing Risks Data’. BMC Medical Research Methodology 20(1). https://doi: 10.1186/s12874-020-01040-9. DOI: https://doi.org/10.1186/s12874-020-01040-9

[12] Messori, Andrea, Vera Damuzzo, Laura Agnoletto, Luca Leonardi, Marco Chiumente, and Daniele Mengato. 2020. ‘A Model-Independent Method to Determine Restricted Mean Survival Time in the Analysis of Survival Curves’. SN Comprehensive Clinical Medicine 2(1):66–68. https://doi: 10.1007/s42399-019-00199-7. DOI: https://doi.org/10.1007/s42399-019-00199-7

[13] Trinquart, Ludovic, Justine Jacot, Sarah C. Conner, and Raphaël Porcher. 2016. ‘Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials’. Journal of Clinical Oncology 34(15):1813–19. https://doi: 10.1200/JCO.2015.64.2488. DOI: https://doi.org/10.1200/JCO.2015.64.2488

[14] Zucker, David M. 1998. ‘Restricted Mean Life with Covariates: Modification and Extension of a Useful Survival Analysis Method’. Journal of the American Statistical Association 93(442):702–9. https://doi: 10.1080/01621459.1998.10473722. DOI: https://doi.org/10.1080/01621459.1998.10473722